PPA24
PPA24 is a PP2A activator with a KD of 8.465 μM for PP2ACα. PPA24 induces cancer cell death via apoptosis. PP2ACα induces ROS generation and decreases the level of c-Myc expression. PPA24 can be used to study colorectal cancer (CRC), Folinic acid , 5-Fluorouracil (HY-90006), and Oxaliplatin (HY-17371) (FOLFOX) -resistant CRC, and melanoma cancer[1][2][3].
Product Specifications
CAS Number
3035032-77-7
UNSPSC
12352005
Target
Apoptosis; c-Myc; ERK; GSK-3; Phosphatase; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Apoptosis; Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-κB; PI3K/Akt/mTOR; Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ppa24.html
Purity
98.09
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
ClC1=CC=C2C(N(C3=CC=CC=C3S2)CCCC[N+]4(C[N@@](C5)C6)C[N@@]6C[N@@]5C4)=C1.[Br-]
Molecular Formula
C22H27BrClN5S
Molecular Weight
508.91
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GSK-3α; GSK-3β
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Human Sestrin-3 (SESN3), partial
Recombinant Human Sestrin-3 (SESN3), partial
Recombinant Human Sestrin-3 (SESN3), partial